Concepedia

Author

Peppy Rebello

University of Oxford

Also Known As

Peppy Rebello

6

Publications

2.1K

Citations

6

H-Index

5

Concepts

All Affiliations

University of OxfordMünchen Klinik SchwabingKU LeuvenInserm
PR

About

Peppy Rebello is an author at University of Oxford specializing in pharmacotherapy, pharmacokinetics, and drug analysis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

85

2

Pharmacology

1

1

85

3

Pharmacokinetics

1

1

85

4

Drug Analysis

1

1

85

5

Pharmacotherapy

1

1

85

Peppy Rebello

×

6

Publications

2.1K

Citations

6

H-Index

YearCitations

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler,

New England Journal of Medicine

2005

1.1K

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

Jeanette Lundin, Eva Kimby, Magnus Björkholm,

Blood

2002

496

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

Emma Morris, Peppy Rebello, Kirsty Thomson,

Blood

2003

193

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration

G Hale, Peppy Rebello, Lee Brettman,

Blood

2004

182

Pharmacokinetics of CAMPATH-1H: assay development and validation

Peppy Rebello, G Hale

Journal of Immunological Methods

2002

85

Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes

G Hale, Peppy Rebello, Ibrahim Al Bakir,

The Journal of Clinical Pharmacology

2010

46

Page 1